563 filings
Page 8 of 29
SC 13D/A
Flynn James E
21 May 21
Larimar Therapeutics / Flynn James E ownership change
5:05pm
8-K
LRMR
Larimar Therapeutics Inc
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
LRMR
Larimar Therapeutics Inc
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am
4
LRMR
Larimar Therapeutics Inc
20 May 21
Larimar Therapeutics / Joseph Truitt ownership change
8:48am
8-K
LRMR
Larimar Therapeutics Inc
18 May 21
Other Events
3:09pm
4
Flynn James E
17 May 21
Larimar Therapeutics / MANAGEMENT COMPANY, L.P. ownership change
5:17pm
4
Leff Jonathan S
17 May 21
Larimar Therapeutics / JONATHAN S LEFF ownership change
5:09pm
4
Daniel Thomas O
17 May 21
Larimar Therapeutics / Thomas O Daniel ownership change
5:08pm
4
LRMR
Larimar Therapeutics Inc
17 May 21
Larimar Therapeutics / Peter Barrett ownership change
5:06pm
4
LRMR
Larimar Therapeutics Inc
17 May 21
Larimar Therapeutics / FRANK E THOMAS ownership change
5:04pm
4
LRMR
Larimar Therapeutics Inc
17 May 21
Larimar Therapeutics / Thomas Edward Hamilton ownership change
4:59pm
8-K
LRMR
Larimar Therapeutics Inc
17 May 21
Submission of Matters to a Vote of Security Holders
6:08am
8-K
LRMR
Larimar Therapeutics Inc
11 May 21
Other Events
8:34am
10-Q
2021 Q1
LRMR
Larimar Therapeutics Inc
Quarterly report
10 May 21
4:30pm
8-K
LRMR
Larimar Therapeutics Inc
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
DEF 14A
LRMR
Larimar Therapeutics Inc
Definitive proxy
14 Apr 21
9:08am
8-K/A
LRMR
Larimar Therapeutics Inc
4 Mar 21
Unaudited Pro Forma Combined Financial Statements
5:16pm
10-K
2020 FY
LRMR
Larimar Therapeutics Inc
Annual report
4 Mar 21
5:09pm
8-K
LRMR
Larimar Therapeutics Inc
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
SC 13G
LRMR
Larimar Therapeutics Inc
2 Mar 21
Larimar Therapeutics / CHI Advisors ownership change
1:58pm